United States · FDA National Drug Code directory

RABEPRAZOLE SODIUM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 60760-972_54d83c32-9a28-8c89-e063-6294a90ae9c2
Product NDC: 60760-972
Form: TABLET, DELAYED RELEASE
Composition / generic term: rabeprazole sodium
Labeler: St. Mary's Medical Park Pharmacy
Marketing category: ANDA
Marketing start / end (source format): 20210506
Source listing expiry: 20271231

Source-listed ingredients

RABEPRAZOLE SODIUM — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

7 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (60760-972-07) · 60760-972-07
30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (60760-972-30) · 60760-972-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →